A biomimetic polyketide-inspired approach to small-molecule ligand discovery

Nature Chemistry

Volumn 4, Issue 2, 2012, Pages 99-104

  Aquino, Claudio ^a   Sarkar, Mohosin ^a   Chalmers, Michael J ^a   Mendes, Kimberly ^a   Kodadek, Thomas ^a   Micalizio, Glenn C ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; POLYKETIDE;

ARTICLE; BIOMIMETICS; CHEMISTRY; DRUG DEVELOPMENT;

BIOMIMETICS; DRUG DISCOVERY; LIGANDS; POLYKETIDES;

EID: 84856400291     PISSN: 17554330     EISSN: 17554349     Source Type: Journal    
DOI: 10.1038/nchem.1200     Document Type: Article

References (44)

1. Schreiber, S. L. Target-oriented and diversity-oriented organic synthesis in drug discovery. Science 287, 1964-1969 (2000).
2. Tan, D. S. Diversity-oriented synthesis: Exploring the intersections between chemistry and biology. Nature Chem. Biol. 1, 74-84 (2005).
3. Spiegel, D. A., Schroeder, F. C., Duvall, J. R. & Schreiber, S. L. An oligomer-based approach to skeletal diversity in small-molecule synthesis. J. Am. Chem. Soc.128, 14766-14767 (2006).
4. Nielsen, T. E. & Schreiber, S. L. Towards the optimal screening collection: A synthesis strategy. Angew. Chem. Int. Ed. 47, 48-56 (2008).
5. Houghten, R. A. General method for the rapid solid-phase synthesis of large numbers of peptides: Specificity of antigen-antibody interaction at the level of individual amino acids. Proc. Natl Acad. Sci. USA 82, 5131-5135 (1985).
6. Thompson, L. A. & Ellman, J. A. Synthesis and applications of small molecule libraries. Chem. Rev. 96, 555-600 (1996).
7. Khosla, C., Kapur, S. & Cane, D. E. Revisiting the modularity of modular polyketide synthases. Curr. Opin. Chem. Biol. 13, 135-143 (2009).
8. Walsh, C. T. The chemical versatility of natural-product assembly lines. Acc. Chem. Res. 41, 4-10 (2008).
9. Nielsen, P. E. Peptide nucleic acids (PNA) in chemical biology and drug discovery. Chem. Biodivers. 7, 786-804 (2010).
10. Seebach, D. & Gardiner, J. β-Peptidic peptidomimetics. Acc. Chem. Res. 41, 1366-1375 (2008).
11. Gellman, S. H. Foldamers: A manifesto. Acc. Chem. Res. 31, 173-180 (1998).
12. Horne, W. S. & Gellman, S. H. Foldamers with heterogeneous backbones. Acc. Chem. Res. 41, 1399-1408 (2008).
13. Nowick, J. S. Exploring β-sheet structure and interactions with chemical model systems. Acc. Chem. Res. 41, 1319-1330 (2008).
14. Robinson, J. A. β-Hairpin peptidomimetics: Design, structures and biological activities. Acc. Chem. Res. 41, 1278-1288 (2008).
15. Schafmeister, C. E., Brown, Z. Z. & Gupta, S. Shape-programmable macromolecules. Acc. Chem. Res. 41, 1387-1398 (2008).
16. Li, X., Wu, T.-D. & Yang, D. α-Aminoxy acids: New possibilities from foldamers to anion receptors and channels. Acc. Chem. Res. 41, 1428-1438 (2008).
17. Summerton, J. Morpholino antisense oligomers: The case for an RNase Hindependent structural type. Biochim. Biophys. Acta. 1489, 141-158 (1999).
18. Dervan, P. B. Molecular recognition of DNA by small molecules. Bioorg. Med. Chem. 9, 2215-2235 (2001).
19. Wuereb, H., Maletic, M., Gildersleeve, J., Pelczer, I. & Kahne, D. Design of an oligosaccharide scaffold that binds in the minor groove of DNA. J. Am. Chem. Soc. 122, 1883-1890 (2000).
20. Davis, J. M., Tsou, L. K. & Hamilton, A. D. Synthetic non-peptide mimetics of α-helices. Chem. Soc. Rev. 36, 326-334 (2007).
21. Kumar, K. & Waldmann, H. Synthesis of natural product inspired compound collections. Angew. Chem. Int. Ed. 48, 3224-3242 (2009).
22. Hoffmann, R. W. Flexible molecules with defined shape-conformational design. Angew. Chem. Int. Ed. 31, 1124-1134 (1992).
23. Simon, R. J. et al. Peptoids: A modular approach to drug discovery. Proc. Natl Acad. Sci. USA 89, 9367-9371 (1992).
24. Zuckermann, R. N., Kerr, J. M., Kent, S. B. H. & Moos, W. H. Efficient method for the preparation of peptoids [oligo(N-substituted glycines)] by submonomer solid-phase synthesis. J. Am. Chem. Soc. 114, 10646-10647 (1992).
25. Zuckermann, R. N. & Kodadek, T. Peptoids as potential therapeutics. Curr. Opin. Mol. Ther. 11, 299-307 (2009).
26. Wilson, D. S., Keefe, A. D. & Szostak, J. W. The use of mRNA display to select high-affinity protein-binding peptides. Proc. Natl Acad. Sci. USA 98, 3750-3755 (2001).
27. Czarnik, A. W. Encoding strategies in combinatorial chemistry. Proc. Natl Acad. Sci. USA 94, 12738-12739 (1997).
28. Ho, G.-J. & Mathre, D. J. Lithium-initiated imide formation. A simple method for N-acylation of 2-oxazolidinones and bornane-2,10-sultam. J. Org. Chem. 60, 2271-2273 (1995).
29. Evans, D. A., Tedrow, J. S., Shaw, J. T. & Downey, C. W. Diastereoselective magnesium halide-catalyzed anti-aldol reactions of chiral N-acyloxazolidinones. J. Am. Chem. Soc. 124, 392-393 (2002).
30. 5-mediated alkoxide rearrangements. J. Org. Chem. 74, 7294-7299 (2009).
31. Xiao, X., Yu, P., Lim, H-S., Sikder, D. & Kodadek, T. Design and synthesis of a cell-permeable synthetic transcription factor mimic. J. Comb. Chem. 9, 592-600 (2007).
32. 53: Growing ever more complex. Nature Rev. Cancer 9, 749-758 (2009).
33. 53 pathway. Nature Rev. Cancer 9, 862-873 (2009).
34. Cochran, A. G. Antagonists of protein-protein interactions. Chem. Biol. 7, R85-R94 (2000).
35. Syka, J. E. P., Coon, J. J., Schroeder, M. J., Shabanowitz, J. & Hunt, D. F. Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. Proc. Natl Acad. Sci. USA 101, 9528-9533 (2004).
36. 53 by covalent binding to the core domain. Cancer Cell 15, 376-388 (2009).
37. 53 by an in silico screened drug. Proc. Natl Acad. Sci. USA 105, 10360-10365 (2008).
38. Coombs, T. C., Lushington, G. H., Douglas, J. & Aubé, J. 1,3-Allylic strain as a strategic diversification element for constructing libraries of substituted 2-arylpiperidines. Angew. Chem. Int. Ed. 50, 2734-2737 (2011).
39. Clemons, P. A. et al. Small molecules of different origins have distinct distributions of structural complexity that correlate with protein-binding profiles. Proc. Natl Acad. Sci. USA 107, 18787-18792 (2010).
40. Morton, D., Leach, S., Cordier, C., Warriner, S. & Nelson, A. Synthesis of natural-product-like molecules with over eighty distinct scaffolds. Angew. Chem. Int. Ed. 48, 104-109 (2009).
41. Luo, T. & Schreiber, S. L. Gold(I)-catalyzed coupling reactions for the synthesis of diverse small molecules using the build/couple/pair strategy. J. Am. Chem. Soc. 131, 5667-5674 (2009).
42. Uchida, T., Rodriguez, M. & Schreiber, S. L. Skeletally diverse small molecules using a build/couple/pair strategy. Org. Lett. 11, 1559-1562 (2009).
43. Reddy, M. M. et al. Identification of candidate IgG biomarkers for Alzheimer's Disease via combinatorial library screening. Cell 144, 132-142 (2011).
44. Udugamasooriya, D. G., Dineen, S. P., Brekken, R. A. & Kodadek, T. A peptoid 'antibody surrogate' that antagonizes VEGF receptor 2 activity. J. Am. Chem. Soc. 130, 5744-5752 (2008).